Gastrointestinal dysmotility in critically ill patients.
Gastrointestinal dysmotility in critically ill patients.
复制标题
DOI：
10.20524/aog.2018.0250
复制
发表时间：
2018-05
影响因子：
2.2
通讯作者：
Kondili E
中科院分区：
文献类型：
--
作者：
Ladopoulos T;Giannaki M;Alexopoulou C;Proklou A;Pediaditis E;Kondili E
胃肠道（GI）动力障碍通常存在于危重病中。据报告，高达60%的重症患者发生了某种形式的胃肠道动力障碍，需要进行治疗干预。它被归因于与基础疾病和所采取的治疗干预措施有关的各种因素。在重症患者中，运动障碍的评估可能具有挑战性，因为用于检测运动异常的可用测试在重症监护室的设置中具有重大局限性。患有GI动力障碍的危重患者需要多方面的治疗方法，以解决多种原因并利用多种药理学途径。在这篇综述中，我们讨论了危重患者胃肠道动力障碍的病理生理，评估和管理。
Gastrointestinal (GI) motility disorders are commonly present in critical illness. Up to 60% of critically ill patients have been reported to experience GI dysmotility of some form necessitating therapeutic intervention. It has been attributed to various factors, related to both the underlying disease and the therapeutic interventions undertaken. The assessment of motility disturbances can be challenging in critically ill patients, as the available tests used to detect abnormal motility have major limitations in the setting of an Intensive Care Unit. Critically ill patients with GI dysmotility require a multifaceted treatment approach that addresses multiple causes and utilizes multiple pharmacological pathways. In this review, we discuss the pathophysiology, assessment and management of GI dysmotility in critically ill patients.